Navigation Links
Thomson Reuters Examines Highly Cited Research in Bioterrorism
Date:5/18/2009

PHILADELPHIA and LONDON, May 18 /PRNewswire/ -- The Healthcare and Science business of Thomson Reuters today announced the results of a study assessing influential research in bioterrorism from 1999 to 2008. The findings appear in the May/June issue of Science Watch (www.sciencewatch.com) and are based on more than 12,000 bioterrorism-related papers published in Thomson Reuters-indexed journals during this time period.

Science Watch ranked the top 25 institutions by both total citations and citation impact (average citations per paper). The United States accounts for 23 of the top 25 institutions in both total citations and citation impact. The U. S. Army took the top spot in total citations with an impressive 9,637 citations to its researchers' work. The U. S. Centers for Disease Control and Prevention ranked second with 6,912 citations, and Johns Hopkins University with 5,006 citations ranked third.

U. S. institutions also led the pack in citation impact, a measure of average citations per published paper. The Institute for Genomic Research had an impact of 62.64 and the New York City Department of Health had an impact of 57.06. Claiming the third spot was the Imperial College of London with an impact of 31.55.

The most cited bioterrorism paper was published in 2001, regarding the causative agent of plague, Yersinia pestis; this paper has been cited nearly 500 times. The second most cited paper, entitled "Anthrax," was published two years before anthrax-tainted mail killed five people in 2001; this paper has now been cited more than 400 times. The third most-cited paper, published in 1999 and garnering more than 375 citations, discusses the use of smallpox as a biological weapon.

For the complete rankings of total citations and citation impact in the bioterrorism field, as well as a rundown of the most cited individual bioterrorism researchers during the time period, visit ScienceWatch.com.

About Thomson Reuters

Thomson Reuters is the world's leading source of intelligent information for businesses and professionals. We combine industry expertise with innovative technology to deliver critical information to leading decision makers in the financial, legal, tax and accounting, scientific, healthcare and media markets, powered by the world's most trusted news organization. With headquarters in New York and major operations in London and Eagan, Minnesota, Thomson Reuters employs more than 50,000 people in 93 countries. For more information, go to www.thomsonreuters.com.


'/>"/>
SOURCE Thomson Reuters
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Thomson Reuters Commemorates World IP Week with Series of Strategic Intellectual Property Seminars Across the U.S.
2. APS Healthcare and Thomson Reuters to Manage New York States Medicaid Clinical Best Practices Review Program
3. Thomson Reuters Names Hottest Researchers and Papers of 2007-2008
4. Despite Decline in Share of Global Output, U.S. Science Impact Still Strong, Says Thomson Reuters
5. The National Cancer Institute Joins the Global Community of Scientists Now Using BIOMARKERcenter From Thomson Reuters
6. The Scientific Business of Thomson Reuters Publishes Its 2008 Liquent Regulatory Affairs Trends Survey Results
7. Thomson Reuters Launches New Biomarkers Solution
8. Thomson Scientific Begins Expansion of Web of Science
9. Thomson Scientific Salutes Nobel Laureate Prize Winners, Many of Whom Were Selected as Thomson Scientific Laureates in 2006
10. Thomson Scientific Publishes Who Is Making The Biggest Splash? - A Quarterly Review of Scientific Literature on Drugs and Therapies From April - June 2007
11. Thomson Scientific to Host Pharmaceutical Vision - A Users Conference for Information, Regulatory Affairs, Competitive Intelligence and Biotechnology Professionals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... and LAGUNA HILLS, Calif. , Oct. ... Cancer Research, London (ICR) and University ... SKY92, SkylineDx,s prognostic tool to risk-stratify patients with multiple myeloma ... MUK nine . The University of Leeds ... partly funded by Myeloma UK, and ICR will perform the ...
(Date:10/10/2017)... Angeles, CA (PRWEB) , ... ... ... Inc., a development-stage cancer-focused pharmaceutical company advancing targeted antibody-drug conjugate (ADC) therapeutics, ... uses of targeted HPLN (Hybrid Polymerized Liposomal Nanoparticle), a technology developed in ...
(Date:10/10/2017)... ... October 10, 2017 , ... USDM Life Sciences ... the life sciences and healthcare industries, announces a presentation by Subbu Viswanathan and ... presentation, “Automating GxP Validation for Agile Cloud Platforms,” will present a revolutionary approach ...
(Date:10/9/2017)... ... October 09, 2017 , ... The Giving Tree ... products targeting the needs of consumers who are incorporating medical marijuana into their ... Phoenix, Arizona. , As operators of two successful Valley dispensaries, The Giving Tree’s ...
Breaking Biology Technology:
(Date:4/13/2017)... 2017 According to a new market research report ... Identity Administration, and Authorization), Service, Authentication Type, Deployment Mode, Vertical, and Region ... expected to grow from USD 14.30 Billion in 2017 to USD 31.75 ... ... MarketsandMarkets Logo ...
(Date:4/11/2017)... , April 11, 2017 NXT-ID, Inc. ... technology company, announces the appointment of independent Directors Mr. ... to its Board of Directors, furthering the company,s corporate governance ... Gino ... we look forward to their guidance and benefiting from their ...
(Date:4/5/2017)... LONDON , April 4, 2017 KEY ... is anticipated to expand at a CAGR of 25.76% ... neurodegenerative diseases is the primary factor for the growth ... full report: https://www.reportbuyer.com/product/4807905/ MARKET INSIGHTS The ... of product, technology, application, and geography. The stem cell ...
Breaking Biology News(10 mins):